BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260605
DTEND;VALUE=DATE:20260607
DTSTAMP:20260508T034518
CREATED:20260331T103221Z
LAST-MODIFIED:20260331T103221Z
UID:196749-1780617600-1780790399@www.bordeaux-neurocampus.fr
SUMMARY:4th International symposium on BPAN disease
DESCRIPTION:Friday 5 and Saturday 6 June\, 2026 \nVenue : Bâtiment Bordeaux Biologie Santé (BBS) \n\nThis is the 4th symposium on BPAN disease organized by the Association “Autour du BPAN” and the NRGen Team (Translational Research on Neurodegenerative Diseases) from INCIA\, Bordeaux. \nBPAN (Beta-Propeller Protein-Associated Neurodegeneration) is a rare neurodegenerative disease that belongs to the NBIA (Neurodegeneration with Brain Iron Accumulation) group. The disease often begins in childhood with developmental delays and epileptic seizures\, then progresses in adulthood to motor and cognitive impairments (parkinsonism\, dementia). To date\, there is no curative treatment. BPAN is caused by mutations in the nuclear WDR45 gene\, which encodes a protein involved in the early stages of autophagy. \nThe symposium will provide an opportunity to discuss the latest findings regarding research models\, pathophysiological mechanisms\, the search for therapeutic molecules\, and clinical advances. It will bring together families of patients\, European researchers\, clinicians and geneticists to share the latest insights on BPAN from a transdisciplinary perspective. \nIt will take place on June 5 and 6\, with a gala dinner on Friday evening aboard a boat on the Garonne River. \nOrganizing Committee Contacts\nJean-Paul LASSERRE\, INCIA – CNRS UMR 5287\, Bordeaux – jean-paul.lasserre@u-bordeaux.fr \nIsabelle COUPRY\, INCIA – CNRS UMR 5287\, Bordeaux – isabelle.coupry@u-bordeau.fr \nProgram and registration\n available via the link below https://www.helloasso.com/associations/autour-du-bpan/evenements/symposium-in-france-5-et-6-juin-2026 \n  \n
URL:https://www.bordeaux-neurocampus.fr/en/event/4th-international-symposium-on-bpan-disease/
CATEGORIES:For scientists,home-event,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260605T140000
DTEND;TZID=Europe/Paris:20260605T140000
DTSTAMP:20260508T034518
CREATED:20260505T095858Z
LAST-MODIFIED:20260505T100201Z
UID:198062-1780668000-1780668000@www.bordeaux-neurocampus.fr
SUMMARY:HDR defense - Mathieu Ducros
DESCRIPTION:Venue: Magendie conference room \nDefense in English \n\nTitle\nNeurophotonics Across Scales \nJury\nDr Alexandra Fragola\, University professor ; spokesperson \nDr Rémi Galland\, Researcher CNRS ; spokesperson \nDr Willy Supatto\, Research Director CNRS ; spokesperson \nDr Cathie Ventalon\, Researcher CNRS CNRS ; examinator \nDr Eirini Papagiakoumou\, Researcher CNRS INSERM ; examinator \nDr Daniel Choquet\, Research Director CNRS ; examinator \n
URL:https://www.bordeaux-neurocampus.fr/en/event/hdr-defense-mathieu-ducros/
LOCATION:Institut François Magendie\, 146 rue Léo saignat\, Bordeaux cedex\, Nouvelle-Aquitaine\, 33077\, France
CATEGORIES:BIC,For scientists,HDR
END:VEVENT
END:VCALENDAR